Prof. Joan-Lluis Vives-Corrons, MD, PhD is Emeritus Prof. at the University of Barcelona and honorary researcher at the Josep Carreras Institute for Leukaemia Research (IJC). His professional activity has centered on rare anemias and other hematologic diseases. For over 30 years, he was the head of the Haematology Laboratory Department (1976-1997) and the Red Blood Cell Pathology Unit (1998-2016) at the Hospital Clinic of Barcelona. As principal investigator of 35 research projects has focused on the molecular and genetic mechanisms of red blood cell (RBC) disorders as the hereditary hemolytic anemias, including enzymopathies, membranopathies, and hemoglobinopathies. In 2002, he coordinated the European Network for Rare and Congenital Anaemias (ENERCA), sponsored by the EC, establishing a pan-European platform for rare anemia clinical care and research. In 2016, ENERCA contributed to the creation of EuroBloodNet, the EU’s Reference Network for Rare Hematological Diseases. He now chairs the Scientific Board of the Rare Anemias International Network (RAIN). Prof. Vives-Corrons has authored over 300 scientific publications and played a key role in the establishment of the official Newborn Screening Program for Sickle-Cell Disease in Catalonia (2015). Since 2017, as an emeritus professor, he continues his research on rare anemias at the IJC.

Dr. Ivone Mirpuri, MD, is a specialist in Anti-Ageing and Hormonal Modulation Medicine. After earning her medical degree with distinction and specializing in Pathology in 1991, she pursued advanced training at the Hertoghe Medical School in Brussels and Cenegenics Medical Institute in Las Vegas. Since 2009, she has focused exclusively on Anti-Ageing Medicine, actively contributing to international congresses, scientific publications, and physician training programs. She is a member of the World Society of Anti-Ageing Medicine and the International Hormone Society and is the founder of GEMAE (Group of Anti-Ageing Medicine Studies).

Prof. Liang Qiao, MD, PhD, is a Principal Research Fellow at the Storr Liver Centre, Westmead Institute for Medical Research (WIMR), and an Adjunct Professor at the University of Sydney. He leads a research group focused on cancer stem cells, liver cancer therapy, stem cell-based treatments for liver diseases, and pre-clinical models such as organoids and PCLS. He has secured over 30 research grants and has published more than 230 peer-reviewed articles in leading journals, including Cell, Hepatology, and Gut. Dr. Qiao holds senior editorial roles across multiple international journals and has been recognized among the world’s top 2% scientists in Oncology, Gastroenterology, and Hepatology since 2022.

Dr Atul Dwivedi is currently working as Assistant Professor and Assistant Director in the Department of Clinical and Basic Sciences , Medical College of Hubei Polytechnic University (HBPU). He is the core member of Research Society of HBPU. He has taken part in thousands of Orthopedic surgeries . During 2013 - 2017 he was research fellow in The First Affiliated Hospital of Zhengzhou university, Henan , PR China.He owns number of International publications . He is not only a reviewer board member in 12 international ,( peer reviewed , ESCI & Pubmed indexed )journals but also Editorial / Advisory Board Member in 6 International Journals . He is the member of Singapore Orthopedic Association & Life time member of Zhengzhou University Alumni Association.

Prof. Joan-Lluis Vives-Corrons, MD, PhD is Emeritus Prof. at the University of Barcelona and honorary researcher at the Josep Carreras Institute for Leukaemia Research (IJC). His professional activity has centered on rare anemias and other hematologic diseases. For over 30 years, he was the head of the Haematology Laboratory Department (1976-1997) and the Red Blood Cell Pathology Unit (1998-2016) at the Hospital Clinic of Barcelona. As principal investigator of 35 research projects has focused on the molecular and genetic mechanisms of red blood cell (RBC) disorders as the hereditary hemolytic anemias, including enzymopathies, membranopathies, and hemoglobinopathies. In 2002, he coordinated the European Network for Rare and Congenital Anaemias (ENERCA), sponsored by the EC, establishing a pan-European platform for rare anemia clinical care and research. In 2016, ENERCA contributed to the creation of EuroBloodNet, the EU’s Reference Network for Rare Hematological Diseases. He now chairs the Scientific Board of the Rare Anemias International Network (RAIN). Prof. Vives-Corrons has authored over 300 scientific publications and played a key role in the establishment of the official Newborn Screening Program for Sickle-Cell Disease in Catalonia (2015). Since 2017, as an emeritus professor, he continues his research on rare anemias at the IJC.